Erlotinib dose-adjusted for smoking status effective as first treatment for head and neck cancer
Head and neck cancers respond well to the anti-cancer drug erlotinib when it is administered before surgery and a stronger dose is given to patients who smoke, according to a study presented at the Multidisciplinary Head ...
Jan 26, 2012
0
0